PA
Perceptive Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-184,525
| Closed | -$9.43M | – | 91 |
|
|
2024
Q4 | $9.43M | Sell |
184,525
-540,173
| -75% | -$27.6M | 0.26% | 61 |
|
|
2024
Q3 | $37M | Sell |
724,698
-751,505
| -51% | -$38.4M | 0.78% | 34 |
|
|
2024
Q2 | $66.1M | Hold |
1,476,203
| – | – | 1.59% | 16 |
|
|
2024
Q1 | $69.1M | Buy |
1,476,203
+220,691
| +18% | +$10.3M | 1.21% | 28 |
|
|
2023
Q4 | $44.7M | Sell |
1,255,512
-8,220
| -0.7% | -$292K | 1% | 32 |
|
|
2023
Q3 | $37.6M | Sell |
1,263,732
-683,205
| -35% | -$20.3M | 1.25% | 25 |
|
|
2023
Q2 | $35.1M | Sell |
1,946,937
-1,607,950
| -45% | -$29M | 1.02% | 32 |
|
|
2023
Q1 | $57.1M | Sell |
3,554,887
-484,389
| -12% | -$7.78M | 1.69% | 17 |
|
|
2022
Q4 | $73.9M | Sell |
4,039,276
-1,281,756
| -24% | -$23.5M | 2.08% | 15 |
|
|
2022
Q3 | $105M | Hold |
5,321,032
| – | – | 3.03% | 9 |
|
|
2022
Q2 | $99.2M | Buy |
5,321,032
+157,515
| +3% | +$2.94M | 3.11% | 7 |
|
|
2022
Q1 | $113M | Hold |
5,163,517
| – | – | 2.27% | 11 |
|
|
2021
Q4 | $147M | Buy |
5,163,517
+1,200,000
| +30% | +$34.1M | 2.26% | 11 |
|
|
2021
Q3 | $83.4M | Hold |
3,963,517
| – | – | 1.21% | 22 |
|
|
2021
Q2 | $74.7M | Buy |
3,963,517
+304,136
| +8% | +$5.73M | 0.97% | 29 |
|
|
2021
Q1 | $51.6M | Hold |
3,659,381
| – | – | 0.65% | 41 |
|
|
2020
Q4 | $51.6M | Hold |
3,659,381
| – | – | 0.55% | 45 |
|
|
2020
Q3 | $57.3M | Hold |
3,659,381
| – | – | 0.84% | 34 |
|
|
2020
Q2 | $59.2M | Buy |
3,659,381
+1,071,428
| +41% | +$17.3M | 0.96% | 26 |
|
|
2020
Q1 | $38M | Hold |
2,587,953
| – | – | 0.99% | 23 |
|
|
2019
Q4 | $64.9M | Hold |
2,587,953
| – | – | 1.29% | 18 |
|
|
2019
Q3 | $38.9M | Hold |
2,587,953
| – | – | 1.05% | 26 |
|
|
2019
Q2 | $64.7M | Hold |
2,587,953
| – | – | 1.48% | 16 |
|
|
2019
Q1 | $58.9M | Hold |
2,587,953
| – | – | 1.66% | 18 |
|
|
2018
Q4 | $77.6M | Hold |
2,587,953
| – | – | 2.95% | 7 |
|
|
2018
Q3 | $74.1M | Buy |
+2,587,953
| New | +$74.1M | 1.98% | 11 |
|